Sponsored
Small interactions, real impact: Building trust in opioid dependence care
An estimated 160,000 Australians are living with opioid dependence1. Whether they’re considering treatment or already receiving it, many face the challenges of a chronic health condition that remains misunderstood and …
Product news for September 2026
Switch to Poly Visc single pack From 1 August 2026, the Poly Visc Lubricating Eye Ointment Twin Pack has been discontinued. After this date, any remaining stock can continue to …
Chronic hand eczema: a pharmacist’s guide to novel therapy
Chronic hand eczema is a particularly challenging condition for patients who experience ongoing inflammation, itch and pain. Potent topical corticosteroids are often required to control flares, but chronic use may …
Every consultation counts: pharmacist-led counselling, nasal technique and follow-up in allergic rhinitis
A deep dive on what pharmacists can ask, explain, demonstrate and review to improve adherence and outcomes for this highly prevalent condition, including the adjunct use of nasal saline to …
Optimising calcium homeostasis: the interplay of vitamin D, K2, magnesium and calcium in bone density and vascular calcification risk
This article explores the synergistic physiological action of calcium, vitamin D, vitamin K2 and magnesium in bone and cardiovascular health and how supplementation may be beneficial for patients with inadequate …
Belly pain unpacked: food, stress and stomach spasms
In this webinar, Dr Brett MacFarlane and A/Prof Treasure McGuire discuss functional abdominal cramping pain and food and stress triggers. This activity guides pharmacists through recognising typical cramping abdominal pain, …
Getting tough on allergies
Allertine (bilastine 20mg) offers symptom relief within one hour that lasts for up to 24 hours. It is the latest second generation antihistamine to be launched in Australia. Allertine is …
Product news for August 2026
New Telfast 6–11 years tablets The Telfast 6–11 Years 30mg mini tablets is a smaller, entry level tablet to help children transition from Oral Liquid for kids to tablets. These …
Allergic rhinitis: essential information for better patient care
Allergic rhinitis (AR) is common, affecting one in five Australians.1 AR not only affects wellbeing through bothersome nasal symptoms, but also impacts quality of life.2 Professor Richard Harvey, (Rhinologist, ENT …
Optimal allergic rhinitis management: the role of the Pharmacist
Takeaway messages  Patients are not considering the impact of Allergic Rhinitis (AR) on daily living and sleep, therefore they are underestimating the severity of AR1-3 Most AR symptoms are moderate …
Allergic rhinitis and the impact on Asthma
Takeaway messages  Allergic rhinitis (AR) and asthma are linked inflammatory airway conditions.1, 2 Co-existence of AR and asthma is associated with poorer asthma control and increased risk of asthma-related hospitalisations.2 …
Myth busting allergic rhinitis: the truth about allergies
There are many misconceptions about allergic rhinitis (AR) and Professor Richard Harvey addresses the more common myths. Â 1 minute snapshot Myth: Allergic rhinitis is just a trivial condition Allergic …